Phoenix™ PK/PD Platform Page

The industry’s most trusted PK/PD platform for non-compartmental analysis (NCA), population PK (popPK), IVIVC, and more.

Phoenix 8.6 Download Page

Phoenix™Download Phoenix 8.6 Accomplish More with Phoenix 8.6 Simplified NCA setup with new options, defaults, and flexible rules, reducing manual effort and improving analysis accuracy Advanced data preparation and streamlined...

Certara Reports Second Quarter 2024 Financial Results Blog Post

Reiterates Full Year 2024 Financial Guidance RADNOR, PA — August 6, 2024– Certara, Inc. (纳斯达克股票代码:CERT), a global leader in model-informed drug development, today reported its financial results for the second…

Pinnacle 21 Clinical Data Exchange

Request a Trial Page

Pinnacle 21 Get Cleaner Non-EDC Vendor Data Faster, with Pinnacle 21 Data Exchange The Pinnacle 21 Enterprise (P21E) Data Exchange platform has everything you need to ease and accelerate vendor...

Certara Talks: PAGE 2024 Blog Post

  Transcript: Hello, and welcome to Certara Talks. I’m Brandon Underwood, senior marketing manager at Certara. Today, I have the pleasure of speaking with Rick Degreef, who is a senior…

Our Story Page

Certara is transforming drug development for goodWelcome to Certara. 我们变革药物开发,造福人类。我们致力于为创新者、研究人员和监管专家提供量身定制的软件和服务解决方案,以满足他们的需求,从而在整个药物开发生命周期中取得成功。...